 FORT LAUDERDALE, Fla., April 30, 2021 GLOBE NEWSWIRE -- Motus GI Holdings, Inc., NASDAQ: MOTS Motus GI or the Company, a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that it has received 510k clearance from the U.S. Food and Drug Administration FDA for a version of the Pure-Vu System that is compatible with gastroscopes used during upper gastrointestinal GI endoscopy procedures to remove blood, blood clots and debris in order to provide a clear field-of-view for the endoscopist. This proprietary technology is the latest innovation for the Pure-Vu System platform that is specifically designed to integrate with therapeutic gastroscopes to enable safe and rapid cleansing during the procedure, while preserving established procedural workflow and techniques. 